Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies

Clinical Oncology

Volumn 28, Issue 9, 2016, Pages e77-e84

  Richards, T M ^a   Bhide, S A ^a,b   Miah, A B ^a   Del Rosario, L ^a   Bodla, S ^a   Thway, K ^a   Gujral, D M ^a   Rooney, K P ^a   Schick, U ^a   McGovern, T ^a   Grove, L ^a   Newbold, K L ^a   Harrington, K J ^a,b   Nutting, C M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Head and neck; IMRT; occult primary; prospective; radiotherapy; squamous cell carcinoma

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; PROTEIN P16;

ACUTE HEART FAILURE; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BALLOON DILATATION; CANCER CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL OUTCOME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DYSPHAGIA; ENTERIC FEEDING; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY; HISTOPATHOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG EDEMA; LYMPHADENOPATHY; MALE; MUCOSA INFLAMMATION; NECK DISSECTION; NON SMALL CELL LUNG CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SQUAMOUS CELL CARCINOMA; STENOSIS; SURVIVAL RATE; TOTAL MUCOSAL IRRADIATION; TREATMENT DURATION; UNDIFFERENTIATED CARCINOMA; XEROSTOMIA; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; HEAD AND NECK NEOPLASMS; MIDDLE AGED; MUCOSA; NEOPLASMS, UNKNOWN PRIMARY; PROCEDURES; RADIATION RESPONSE; RADIOTHERAPY DOSAGE; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASMS, UNKNOWN PRIMARY; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED; XEROSTOMIA;

EID: 84969916983     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2016.04.035     Document Type: Article

References (28)

1. [1] Miller, F.R., Hussey, D., Beeram, M., Eng, T., McGuff, H.S., Otto, R.A., Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg 131:7 (2005), 626–629.
2. [2] Grau, C., Johansen, L.V., Jakobsen, J., Geertsen, P., Andersen, E., Jensen, B.B., Cervical lymph node metastases from unknown primary tumours – results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 55:2 (2000), 121–129.
3. [3] Strojan, P., Ferlito, A., Langendijk, J.A., et al. Contemporary management of lymph node metastases from an unknown primary to the neck: II. A review of therapeutic options. Head Neck 35:2 (2013), 286–293.
4. [4] Galloway, T.J., Ridge, J.A., Management of squamous cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol 33:29 (2015), 3328–3337.
5. [5] National Comprehensive Cancer Network (NCCN) Guidelines. Head and Neck Cancers. Version 1, 2014 [cited 2014 5 May]; Available from: http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.
6. [6] Nieder, C., Gregoire, V., Ang, K.K., Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?. Int J Radiat Oncol Biol Phys 50:3 (2001), 727–733.
7. [7] Gregoire, V., Eisbruch, A., Hamoir, M., Levendag, P., Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 79:1 (2006), 15–20.
8. [8] Gregoire, V., Levendag, P., Ang, K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:3 (2003), 227–236.
9. [9] Wilkins, A.C., Rosenfelder, N., Schick, U., et al. Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: a matched-pair analysis. Oral Oncol 49:6 (2013), 615–619.
10. [10] Bentzen, S.M., Saunders, M.I., Dische, S., Bond, S.J., Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 60:2 (2001), 123–135.
11. [11] Ang, K.K., Harris, J., Wheeler, R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. New Engl J Med 363:1 (2010), 24–35.
12. [12] Sher, D.J., Balboni, T.A., Haddad, R.I., et al. Efficacy and toxicity of chemoradiotherapy using IMRT for unknown primary of head and neck. Int J Radiat Oncol Biol Phys 80:5 (2011), 1405–1411.
13. [13] Shoushtari, A., Saylor, D., Kerr, K., et al. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 81:3 (2011), e83–e91.
14. [14] Villeneuve, H., Despres, P., Fortin, B., et al. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with IMRT. Int J Radiat Oncol Biol Phys 82:5 (2012), 1866–1871.
15. [15] Chen, A.M., Li, B.Q., Farwell, D.G., et al. Improved dosimetric and clinical outcomes with IMRT for head and neck cancer of unknown primary origin. Int J Radiat Oncol Biol Phys 79:3 (2011), 756–762.
16. [16] Frank, S.J., Rosenthal, D.I., Petuksiri, J., et al. IMRT for cervical node squamous cell carcinoma metastases from unknown head and neck primary site: M.D. Anderson Cancer Centre outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 78:4 (2010), 1005–1010.
17. [17] Lu, H.M., Yao, M., Tan, H.M., Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated. Oral Oncol 45:6 (2009), 474–479.
18. [18] Klem, M.L., Mechalakos, J.G., Wolden, S.L., et al. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Int J Radiat Oncol Biol Phys 70:4 (2008), 1100–1107.
19. [19] Madani, I., Vakaet, L., Bonte, K., Boterberg, T., De Neve, W., Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys 71:4 (2008), 1158–1166.
20. [20] Janssen, S., Glanzmann, C., Huber, G., Studer, G., Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary. Strahlenther Onkol 190:4 (2014), 386–393.
21. [21] Pignon, J.P., Le Maitre, A., Maillard, E., Bourhis, J., Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:1 (2009), 4–14.
22. [22] Chen, A.M., Farwell, D.G., Lau, D.H., Li, B.Q., Luu, Q., Donald, P.J., Radiation therapy in the management of head and neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?. Int J Radiat Oncol Biol Phys 81:2 (2011), 346–352.
23. [23] Tribius, S., Hoffmann, A.S., Bastrop, S., et al. HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome. Oral Oncol 48:11 (2012), 1178–1184.
24. [24] Wallace, A., Richards, G.M., Harari, P.M., et al. Head and neck squamous cell carcinoma from an unknown primary site. Am J Otolaryngol 32:4 (2011), 286–290.
25. [25] Berrington de Gonzalez, A., Curtis, R.E., Kry, S.F., et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12:4 (2011), 353–360.
26. [26] Bartkowiak, D., Humble, N., Suhr, P., et al. ​Second cancer after radiotherapy, 1981–2007. Radiother Oncol 105:1 (2012), 122–126.
27. [27] Grantzau, T., Mellemkjaer, L., Overgaard, J., Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol 106:1 (2013), 42–49.
28. [28] Berrington de Gonzalez, A., Gilbert, E., Curtis, R., et al. Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship. Int J Radiat Oncol Biol Phys 86:2 (2013), 224–233.